Leeds UK (PRWEB) August 30, 2008
Life sciences industry speakers include Dr Nigel Greene of Pfizer and Dr Scott Boyer of Astra Zeneca. Both will be covering current approaches towards toxicity prediction from a pharmaceutical industry perspective. Dr Greene will focus upon perceived strengths and limitations of these.
Dr Héctor De León of Entelos Inc. will be presenting on emerging technologies in toxicity prediction, with a focus on Antiatherogenic Therapies and Cardiovascular Toxicity. Dr Cameron MacKay of the Unilever Safety & Environmental Assurance Centre will also be speaking about emerging areas from the perspective of the consumer products industry. Professor Chihae Yang will be representing Leadscope Inc. at the event to present on The Role of Predictive Data Mining in Understanding Toxicity.
The Lhasa Symposium will also feature presentations from speakers representing academia including Professor Hawkins of the University of Minnesota and Dr Mark Cronin, Professor of Predictive Toxicology in the School of Pharmacy and Chemistry at Liverpool John Moores University. Presenters from various regulatory bodies including the US Food and Drug Administration and European Chemicals Bureau will also be speaking at the event.
The Symposium will consist of three sessions dealing with current approaches to toxicity prediction, strengths and limitations of those approaches and analysis of emerging areas and technologies. A panel discussion session will conclude the event by exploring future needs and challenges in toxicity prediction. During this session expert panellists will invite audience participation and offer views and opinions from regulatory, commercial and academic perspectives.
The Lhasa Symposium will take place on December 8th and 9th 2008 at the University of Cambridge, UK. For further information and to register please visit http://www.lhasasymposium.com .